Home » Newsletters » BioWorld

BioWorld

Sep. 17, 1997

View Archived Issues

Mutant Chemokine Gene Not Sole Arbiter Of HIV T Cell Entry

Cambridge Neuroscience Suffers Second Setback With Cerastat

OXiGENE's Sensamide Data May Support Neu-Sensamide

Other News To Note

Advancements And Appointments

Senate Again Limits Debate Of FDA Bill; Kennedy Stalling

Signal Pharmaceuticals Edges Toward IPO With $12M Financing

Megabios Completes $30M IPO For Gene Therapy Products